Skip to content

Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

  • Home
  • Visit our other Journals
    • VJHemOnc
    • VJOncology
    • VJDementia
    • VJRegenmed
    • VJHemOnc-E
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjdementia
VJNeurology
Logo
  • Diseases
    Parkinson's Disease
    Multiple Sclerosis and Related Disorders
    Headache
    Amyotrophic Lateral Sclerosis
    Epilepsy
    Sleep Disorders
    Stroke
    Neuromuscular Disorders
    Movement Disorders
    View all Diseases
  • Topics
    Biology
    Diagnostics
    Trial Updates
    Treatment
    Prevention
    Surgery
    Imaging
    Genetics
    COVID-19
    View all Topics
  • Conferences
    MDS 2023
    EAN 2023
    AHS 2023
    CMSC 2023
    ESOC 2023
    AAN 2023
    View all Conferences
  • Features
  • Podcasts
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Entacapone

Levodopa jejunal infusions: patient selection & challenges 4:39
Levodopa jejunal infusions: patient selection & challenges
Dag Nyholm • 25 Aug 2023
Practical guidance for healthcare teams starting patients on LECIG 1:18
Practical guidance for healthcare teams starting patients on LECIG
Dag Nyholm • 24 Mar 2023
Long-term follow up of LECIG use in Sweden 7:08
Long-term follow up of LECIG use in Sweden
Dag Nyholm • 24 Mar 2023
COMT inhibitors for Parkinson’s disease: clinical updates 1:06
COMT inhibitors for Parkinson’s disease: clinical updates
Margherita Fabbri • 17 Sep 2022
How can continuous dopaminergic delivery improve outcomes in PD? 0:51
How can continuous dopaminergic delivery improve outcomes in PD?
Eric Freire-Alvarez • 16 Sep 2022
Early identification of suboptimal PD control to improve care 0:59
Early identification of suboptimal PD control to improve care
Eric Freire-Alvarez • 15 Sep 2022
Opicapone for pain in PD: the OCEAN study 2:13
Opicapone for pain in PD: the OCEAN study
K. Ray-Chaudhuri • 27 Jun 2022
The ELEGANCE study: levodopa-entacapone-carbidopa intestinal gel in Parkinson’s disease 1:13
The ELEGANCE study: levodopa-entacapone-carbidopa intestinal gel in Parkinson’s disease
K. Ray-Chaudhuri • 27 Jun 2022
Opicapone versus entacapone for early morning dystonia in Parkinson’s disease 2:31
Opicapone versus entacapone for early morning dystonia in Parkinson’s disease
Fabrizio Stocchi • 25 Jun 2022
Latest approaches to improve the delivery of levodopa 2:32
Latest approaches to improve the delivery of levodopa
Fabrizio Stocchi • 25 Jun 2022
COMT inhibitors for motor fluctuations in Parkinson’s disease 1:18
COMT inhibitors for motor fluctuations in Parkinson’s disease
Heinz Reichmann • 22 Mar 2022
LECIG for motor fluctuations in Parkinson’s disease 3:28
LECIG for motor fluctuations in Parkinson’s disease
Dag Nyholm • 24 Jun 2021
Opicapone shows better motor performance in Parkinson’s disease compared to entacapone 3:37
Opicapone shows better motor performance in Parkinson’s disease compared to entacapone
Joaquim Ferreira • 4 Sep 2020
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJNeurology via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJNeurology logo
The content of VJNeurology is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy